@ARPA_H Our fearless leader, Dr. Sorena Nadaf-Rahrov is looking forward to joining the PCX Innovation Summit tomorrow !
Cancer Center Informatics Society
Verified account This account is verified. Learn more@CI4CC
Join Leading Translational Scientists and Executive Leaders in Oncology, AI, and Informatics for the 26th Cancer Centers Symposium in Baltimore this Fall
2.3K Following 4K Followers 47K Posts
Latest posts 5
Day 2 Welcome and Keynote Presentation from the National Cancer Institute: Dr. Warren Kibbe, Deputy Director NCI : “From Data to Discovery: Shaping the Future” @theNCI @wakibbe
ci4cc.org/fall-2026-work…
ci4cc.org/fall-2026-work…
@NateraGenetics presenting the Life Sciences Distinguished Keynote at the 26th Cancer Center Informatics Symposium.
Aaron Brauser, PhD - Vice President, Health System Products, Natera : “Leveraging MRD in Real World Data Applications”
MRD in Real World Data Applications will explore how molecular residual disease (MRD) testing can enrich real-world oncology data and support evidence generation. Natera will discuss opportunities to connect MRD results with longitudinal clinical information to better understand recurrence risk, treatment response, and patient outcomes, with implications for precision oncology and clinical research.
ci4cc.org/fall-2026-work…
Aaron Brauser, PhD - Vice President, Health System Products, Natera : “Leveraging MRD in Real World Data Applications”
MRD in Real World Data Applications will explore how molecular residual disease (MRD) testing can enrich real-world oncology data and support evidence generation. Natera will discuss opportunities to connect MRD results with longitudinal clinical information to better understand recurrence risk, treatment response, and patient outcomes, with implications for precision oncology and clinical research.
ci4cc.org/fall-2026-work…
#ci4cc26 Distinguished Keynote: “From Scientific Discovery to Patient Therapy” with Dr. Larry W. Kwak, MD, PhD - Scientific Founder & Interim CEO, PeproMene Bio:
From Scientific Discovery to Patient Therapy will trace the development of BAFF-R–targeted CAR T-cell therapy for relapsed or refractory B-cell lymphomas. Dr. Kwak will share the journey from target discovery and preclinical research to clinical evaluation, highlighting early clinical findings and the scientific, manufacturing, and operational challenges of translating a novel cellular therapy into patient care
ci4cc.org/fall-2026-work…
From Scientific Discovery to Patient Therapy will trace the development of BAFF-R–targeted CAR T-cell therapy for relapsed or refractory B-cell lymphomas. Dr. Kwak will share the journey from target discovery and preclinical research to clinical evaluation, highlighting early clinical findings and the scientific, manufacturing, and operational challenges of translating a novel cellular therapy into patient care
ci4cc.org/fall-2026-work…
Coming up next on Stage ! Life Sciences Distinguished Keynote with Seema Verma, GM and EVP Oracle Health and Life Sciences: "Shaping Tomorow's Cancer Care with Oracle" @OracleNews @Oracle @OracleHealthSci @OracleHealth @HealthcareSeema #ci4cc26
ci4cc.org/fall-2026-work…
ci4cc.org/fall-2026-work…